SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-24-000385
Filing Date
2024-04-01
Accepted
2024-04-01 09:16:01
Documents
84
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bcli-20231231x10k.htm   iXBRL 10-K 2535448
2 EX-10.69 bcli-20231231xex10d69.htm EX-10.69 42499
3 EX-10.70 bcli-20231231xex10d70.htm EX-10.70 13412
4 EX-10.71 bcli-20231231xex10d71.htm EX-10.71 14337
5 EX-10.72 bcli-20231231xex10d72.htm EX-10.72 14235
6 EX-10.73 bcli-20231231xex10d73.htm EX-10.73 14238
7 EX-21 bcli-20231231xex21.htm EX-21 4751
8 EX-23.1 bcli-20231231xex23d1.htm EX-23.1 7507
9 EX-31.1 bcli-20231231xex31d1.htm EX-31.1 9535
10 EX-31.2 bcli-20231231xex31d2.htm EX-31.2 9710
11 EX-32.1 bcli-20231231xex32d1.htm EX-32.1 5325
12 EX-32.2 bcli-20231231xex32d2.htm EX-32.2 5372
13 EX-97.1 bcli-20231231xex97d1.htm EX-97.1 32071
14 GRAPHIC bcli-20231231x10k001.jpg GRAPHIC 5624
  Complete submission text file 0001410578-24-000385.txt   7492490

Data Files

Seq Description Document Type Size
15 EX-101.SCH bcli-20231231.xsd EX-101.SCH 45318
16 EX-101.CAL bcli-20231231_cal.xml EX-101.CAL 34090
17 EX-101.DEF bcli-20231231_def.xml EX-101.DEF 159853
18 EX-101.LAB bcli-20231231_lab.xml EX-101.LAB 339232
19 EX-101.PRE bcli-20231231_pre.xml EX-101.PRE 292783
88 EXTRACTED XBRL INSTANCE DOCUMENT bcli-20231231x10k_htm.xml XML 983687
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36641 | Film No.: 24805876
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)